首页> 美国卫生研究院文献>SAGE Open Medicine >Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected treatment-experienced adults: Week 48 results of a phase IV trial

【2h】

Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected treatment-experienced adults: Week 48 results of a phase IV trial

机译：依那韦与达那那韦/利托那韦以外的抗逆转录病毒药物联合治疗HIV-1感染有治疗经验的成年人：IV期试验第48周的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:VIOLIN (TMC125IFD3002; ) evaluated the safety, tolerability, and pharmacokinetics of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected patients.

机译：目的：VIOLIN（TMC125IFD3002;）评价了HIV-1感染患者中依那韦与达那那韦/利托那韦以外的抗逆转录病毒药物的安全性，耐受性和药代动力学。

著录项

期刊名称 SAGE Open Medicine
作者
Eduardo Arathoon; Asad Bhorat; Rodica Silaghi; Herta Crauwels; Ludo Lavreys; Lotke Tambuyzer; Ben Van Baelen; Simon Vanveggel; Magda Opsomer;
展开▼
作者单位

展开▼
年(卷),期 2017(5),-1
年度 2017
页码 2050312116686482
总页数 9
原文格式 PDF
正文语种
中图分类药学;
关键词
Etravirine safety efficacy virology pharmacokinetics;

机译：依曲韦林;安全性;功效;病毒学;药代动力学;

相似文献

外文文献
中文文献
专利

1. Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial: [J] . Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, Sage Open Medicine . 2017,第2期

机译：依曲韦林与达那那韦/利托那韦以外的抗逆转录病毒药物联合治疗HIV-1感染，有治疗经验的成年人：IV期试验的第48周结果：
2. Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults [J] . Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, Journal of the International Aids Society . 2014,第4Suppla3期

机译：在接受HIV-1感染，治疗经验丰富的成年人中，埃曲韦林与达那那韦/利托那韦以外的抗逆转录病毒药物的IV期试验的第48周结果
3. Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults [J] . Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, Journal of the International Aids Society . 2014,第4Suppla3期

机译：在接受HIV-1感染，治疗经验丰富的成年人中，埃曲韦林与达那那韦/利托那韦以外的抗逆转录病毒药物的IV期试验的第48周结果
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Validation of a UPLC-MS/MS method for the simultaneous measurement of the antiretroviral drugs atazanavir, darunavir, efavirenz, etravirine, lopinavir, raltegravir, ritonavir from human plasma. [D] . Patel, Rutva. 2012

机译：用于从人血浆中同时测定抗逆转录病毒药物阿扎那韦，达鲁那韦，依非韦伦，依曲韦林，洛匹那韦，拉格列韦，利托那韦的UPLC-MS / MS方法的验证。
6. Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults [O] . Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, 2014

机译：在接受HIV-1感染治疗经验丰富的成年人中埃曲韦林与达那那韦/利托那韦以外的抗逆转录病毒药物的IV期试验的第48周结果
7. Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial [O] . Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, 2017

机译：Etravirine与darunavir / ritonavir以外的抗逆转录病毒联合用于HIV-1感染的治疗经验成人：IV期试验的第48周结果

Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected treatment-experienced adults: Week 48 results of a phase IV trial

摘要

著录项

相似文献

相关主题

期刊订阅